Related Experiment Video
Updated: Jul 23, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Shh-Gli2-Runx2 inhibits vascular calcification
Aoran Huang1, Tianhua Xu1, Xiaomei Lu2
1Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.
Insights
Shh signaling, a key pathway in bone formation, was found to be decreased in vascular calcification (VC). Restoring Shh levels inhibited VC, suggesting Shh as a potential therapeutic target for this condition.
Area of Science:
- Cardiovascular Biology
- Renal Medicine
- Molecular Biology
Background:
- Vascular calcification (VC) is a common complication in chronic kidney disease (CKD) and significantly increases mortality risk.
- Shh, a ligand in Hedgehog (Hh) signaling, is involved in osteogenesis and cardiovascular diseases, but its role in VC remains unexplored.
Purpose of the Study:
- To investigate the role of Shh signaling in the development of vascular calcification (VC) in chronic kidney disease (CKD).
- To explore Shh as a potential therapeutic target for treating VC.
Main Methods:
- Vascular smooth muscle cells (VSMCs) were induced to calcify using inorganic phosphorus.
- Vascular calcification (VC) was induced in mice using an adenine diet supplemented with phosphorus.
- Shh signaling pathway modulation was achieved using agonists (SAG) and antagonists (CPN), and gene manipulation (overexpression/silencing) of Shh and Gli2.
Main Results:
- Shh levels were reduced in calcified VSMCs, arteries of mice with VC, and radial arteries of CKD patients with VC.
- Shh overexpression inhibited VSMC calcification, while Shh silencing accelerated it.
- Hedgehog signaling agonist (SAG) alleviated VC, whereas antagonist (CPN) worsened it.
- Shh inhibited VC via Gli2, which promoted Runx2 degradation, independent of Smurf1 and Cullin4B.
Conclusions:
- Shh signaling plays a protective role against vascular calcification (VC).
- The study elucidates the mechanism of Shh in preventing VC through Gli2-mediated Runx2 degradation.
- Shh emerges as a promising therapeutic target for managing vascular calcification in CKD.
Background:
In patients with chronic kidney disease (CKD), vascular calcification (VC) is common and is associated with a higher risk of all-cause mortality. Shh, one ligand for Hedgehog (Hh) signaling, participates in osteogenesis and several cardiovascular diseases. However, it remains unclear whether Shh is implicated in the development of VC.
Methods:
Inorganic phosphorus 2.6 mM was used to induce vascular smooth muscle cells (VSMCs) calcification. Mice were fed with adenine diet supplement with 1.2% phosphorus to induce VC.
Results:
Shh was decreased in VSMCs exposed to inorganic phosphorus, calcified arteries in mice fed with an adenine diet, as well as radial arteries from patients with CKD presenting VC. Overexpression of Shh inhibited VSMCs ostosteoblastic differentiation and calcification, whereas its silencing accelerated these processes. Likewise, mice treated with smoothened agonist (SAG; Hh signaling agonist) showed alleviated VC, and mice treated with cyclopamine (CPN; Hh signaling antagonist) exhibited severe VC. Additionally, overexpression of Gli2 significantly reversed the pro-calcification effect of Shh silencing on VSMCs, suggesting that Shh inhibited VC via Gli2. Mechanistically, Gli2 interacted with Runx2 and promoted its ubiquitin proteasomal degradation, therefore protecting against VC. Of interest, the pro-degradation effect of Gli2 on Runx2 was independent of Smurf1 and Cullin4B.
Conclusions:
Our study provided deeper insight to the pathogenesis of VC, and Shh might be a novel potential target for VC treatment.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity

